Gsa Capital Partners LLP Cor Medix Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Cor Medix Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 11,825 shares of CRMD stock, worth $148,640. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,825

Previous 42,119 71.92%

Holding current value

$148,640

Previous $182,000 47.25%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$3.64 - $8.23 $110,270 - $249,319	-30,294 Reduced 71.92%	11,825 $96,000
Q2 2024 Aug 15, 2024	BUY	$4.08 - $6.39 $171,845 - $269,140	42,119 New	42,119 $182,000
Q4 2023 Feb 16, 2024	BUY	$3.0 - $4.01 $74,163 - $99,131	24,721 New	24,721 $92,000
Q2 2023 Aug 14, 2023	SELL	$3.94 - $5.8 $166,780 - $245,514	-42,330 Reduced 52.49%	38,311 $151,000
Q1 2023 May 12, 2023	SELL	$3.22 - $4.61 $180,046 - $257,768	-55,915 Reduced 40.95%	80,641 $333,000
Q4 2022 Feb 13, 2023	BUY	$2.81 - $4.45 $323,012 - $511,531	114,951 Added 532.06%	136,556 $576,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $8,617 - $22,981	3,056 Added 16.48%	21,605 $61,000
Q2 2022 Aug 09, 2022	SELL	$2.73 - $5.61 $80,461 - $165,343	-29,473 Reduced 61.37%	18,549 $75,000
Q1 2022 May 11, 2022	BUY	$3.83 - $6.24 $51,586 - $84,046	13,469 Added 38.98%	48,022 $263,000
Q4 2021 Feb 14, 2022	BUY	$4.47 - $5.56 $97,043 - $120,707	21,710 Added 169.04%	34,553 $157,000
Q3 2021 Nov 12, 2021	SELL	$4.46 - $7.11 $2,916 - $4,649	-654 Reduced 4.85%	12,843 $60,000
Q2 2021 Aug 05, 2021	SELL	$6.05 - $10.09 $6,842 - $11,411	-1,131 Reduced 7.73%	13,497 $93,000
Q1 2021 May 10, 2021	BUY	$6.84 - $17.58 $100,055 - $257,160	14,628 New	14,628 $146,000
Q2 2020 Aug 11, 2020	SELL	$3.08 - $6.56 $65,998 - $140,567	-21,428 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$2.35 - $7.08 $50,355 - $151,710	21,428 New	21,428 $77,000

Others Institutions Holding CRMD

# of Institutions

110

Shares Held

17.4M

Call Options Held

134K

Put Options Held

441K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $518M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Cor Medix Inc. Transaction History